Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01597-24 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Yu-Han Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, USA. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Anti-Bacterial Agents, Febrile Neutropenia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Febrile neutropenia (FN) is a serious complication in patients with hematologic malignancies following treatments such as chemotherapy and hematopoietic stem cell transplantation. It is typically managed with broad-spectrum antibiotics (BSA), but the optimal duration of BSA therapy remains controversial. This meta-analysis aimed to assess the clinical efficacy and safety of early antibiotic de-escalation in patients with hematologic malignancies with FN before hematopoietic recovery, compared to those who continued BSA until hematopoietic recovery. Statistical analysis included pooled odds ratios (OR) for mortality and secondary adverse outcomes, along with subgroup analysis to identify patient populations that may benefit from early de-escalation. Ten studies, mostly retrospective observational designs, were included. Early de-escalation significantly reduced mortality risk (OR 0.20, 95% CI 0.06–0.69). Subgroup analyses showed mortality benefits in older patients (>55 years old, OR 0.42, 95% CI 0.18–0.98) and in higher-quality studies (OR 0.07, 95% CI 0.01–0.62). No significant differences were observed for infection-related ICU admissions, bacteremia, recurrent fever, or Clostridium difficile infection (CDI). In conclusion, early de-escalation of BSA in patients with hematologic malignancies and developing FN after treatment significantly reduces mortality risk without increasing major adverse events. These findings support the use of early de-escalation and highlight the need for personalized strategies to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey, USA.
- College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Ophthalmology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
- Jacob's School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
- Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.
ORCID-Profile: Yu-Han Chen, Andrea Yue-En Sun, Karishma Narain, Cho-Hao Lee
Zitieren
APA
Chen, Y. H., Sun, A. Y. E., Narain, K., Chang, W. C., Yang, C., Chen, P. H., Jhou, H. J., Dai, M. S., Rastogi, N., & Lee, C. H. (2025). Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01597-24
Vancouver
Chen YH, Sun AYE, Narain K, Chang WC, Yang C, Chen PH, et al. Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01597-24
BibTeX
@article{Chen2025,
author = {Chen, Yu-Han and Sun, Andrea Yue-En and Narain, Karishma and Chang, Wei-Cheng and Yang, Chieh and Chen, Po-Huang and Jhou, Hong-Jie and Dai, Ming-Shen and Rastogi, Natasha and Lee, Cho-Hao},
title = {Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01597-24}
}
EUVIMED